177 related articles for article (PubMed ID: 28337328)
21. Sequence-Specific Modifications Enhance the Broad-Spectrum Antiviral Response Activated by RIG-I Agonists.
Chiang C; Beljanski V; Yin K; Olagnier D; Ben Yebdri F; Steel C; Goulet ML; DeFilippis VR; Streblow DN; Haddad EK; Trautmann L; Ross T; Lin R; Hiscott J
J Virol; 2015 Aug; 89(15):8011-25. PubMed ID: 26018150
[TBL] [Abstract][Full Text] [Related]
22. Broad-spectrum antiviral activity of the IMP dehydrogenase inhibitor VX-497: a comparison with ribavirin and demonstration of antiviral additivity with alpha interferon.
Markland W; McQuaid TJ; Jain J; Kwong AD
Antimicrob Agents Chemother; 2000 Apr; 44(4):859-66. PubMed ID: 10722482
[TBL] [Abstract][Full Text] [Related]
23. Targeting Innate Immunity for Antiviral Therapy through Small Molecule Agonists of the RLR Pathway.
Pattabhi S; Wilkins CR; Dong R; Knoll ML; Posakony J; Kaiser S; Mire CE; Wang ML; Ireton RC; Geisbert TW; Bedard KM; Iadonato SP; Loo YM; Gale M
J Virol; 2015 Dec; 90(5):2372-87. PubMed ID: 26676770
[TBL] [Abstract][Full Text] [Related]
24. Antiviral activity of lanatoside C against dengue virus infection.
Cheung YY; Chen KC; Chen H; Seng EK; Chu JJ
Antiviral Res; 2014 Nov; 111():93-9. PubMed ID: 25251726
[TBL] [Abstract][Full Text] [Related]
25. Anticancer kinase inhibitors impair intracellular viral trafficking and exert broad-spectrum antiviral effects.
Bekerman E; Neveu G; Shulla A; Brannan J; Pu SY; Wang S; Xiao F; Barouch-Bentov R; Bakken RR; Mateo R; Govero J; Nagamine CM; Diamond MS; De Jonghe S; Herdewijn P; Dye JM; Randall G; Einav S
J Clin Invest; 2017 Apr; 127(4):1338-1352. PubMed ID: 28240606
[TBL] [Abstract][Full Text] [Related]
26. New insights into the antiviral activity of nordihydroguaiaretic acid: Inhibition of dengue virus serotype 1 replication.
Martinez F; Ghietto LM; Lingua G; Mugas ML; Aguilar JJ; Gil P; Pisano MB; Marioni J; Paglini MG; Contigiani MS; Núñez-Montoya SC; Konigheim BS
Phytomedicine; 2022 Nov; 106():154424. PubMed ID: 36126544
[TBL] [Abstract][Full Text] [Related]
27. Cucurbit[7]uril as a Broad-Spectrum Antiviral Agent against Diverse RNA Viruses.
Quan J; Zhang X; Ding Y; Li S; Qiu Y; Wang R; Zhou X
Virol Sin; 2021 Oct; 36(5):1165-1176. PubMed ID: 34037947
[TBL] [Abstract][Full Text] [Related]
28. Mathematical modeling of plus-strand RNA virus replication to identify broad-spectrum antiviral treatment strategies.
Zitzmann C; Dächert C; Schmid B; van der Schaar H; van Hemert M; Perelson AS; van Kuppeveld FJM; Bartenschlager R; Binder M; Kaderali L
bioRxiv; 2022 Jul; ():. PubMed ID: 35923314
[TBL] [Abstract][Full Text] [Related]
29. Expanding the anti-flaviviral arsenal: Discovery of a baicalein-derived Compound with potent activity against DENV and ZIKV.
Putri GN; Gudla CS; Singh M; Ng CH; Idris FFH; Oo Y; Tan JHY; Wong JFJ; Chu JJH; Selvam V; Selvaraj SS; Shandil RK; Narayanan S; Alonso S
Antiviral Res; 2023 Dec; 220():105739. PubMed ID: 37944824
[TBL] [Abstract][Full Text] [Related]
30. Enhancing the antiviral potency of ER α-glucosidase inhibitor IHVR-19029 against hemorrhagic fever viruses in vitro and in vivo.
Ma J; Zhang X; Soloveva V; Warren T; Guo F; Wu S; Lu H; Guo J; Su Q; Shen H; Solon E; Comunale MA; Mehta A; Guo JT; Bavari S; Du Y; Block TM; Chang J
Antiviral Res; 2018 Feb; 150():112-122. PubMed ID: 29253498
[TBL] [Abstract][Full Text] [Related]
31. N-Phenylpyridine-3-Carboxamide and 6-Acetyl-1H-Indazole Inhibit the RNA Replication Step of the Dengue Virus Life Cycle.
Sow AA; Pahmeier F; Ayotte Y; Anton A; Mazeaud C; Charpentier T; Angelo L; Woo S; Cerikan B; Falzarano D; Abrahamyan L; Lamarre A; Labonté P; Cortese M; Bartenschlager R; LaPlante SR; Chatel-Chaix L
Antimicrob Agents Chemother; 2023 Feb; 67(2):e0133122. PubMed ID: 36700643
[TBL] [Abstract][Full Text] [Related]
32. Understanding the Mechanism of the Broad-Spectrum Antiviral Activity of Favipiravir (T-705): Key Role of the F1 Motif of the Viral Polymerase.
Abdelnabi R; Morais ATS; Leyssen P; Imbert I; Beaucourt S; Blanc H; Froeyen M; Vignuzzi M; Canard B; Neyts J; Delang L
J Virol; 2017 Jun; 91(12):. PubMed ID: 28381577
[TBL] [Abstract][Full Text] [Related]
33. Characterization of the mode of action of a potent dengue virus capsid inhibitor.
Scaturro P; Trist IM; Paul D; Kumar A; Acosta EG; Byrd CM; Jordan R; Brancale A; Bartenschlager R
J Virol; 2014 Oct; 88(19):11540-55. PubMed ID: 25056895
[TBL] [Abstract][Full Text] [Related]
34. Labyrinthopeptins Exert Broad-Spectrum Antiviral Activity through Lipid-Binding-Mediated Virolysis.
Prochnow H; Rox K; Birudukota NVS; Weichert L; Hotop SK; Klahn P; Mohr K; Franz S; Banda DH; Blockus S; Schreiber J; Haid S; Oeyen M; Martinez JP; Süssmuth RD; Wink J; Meyerhans A; Goffinet C; Messerle M; Schulz TF; Kröger A; Schols D; Pietschmann T; Brönstrup M
J Virol; 2020 Jan; 94(2):. PubMed ID: 31666384
[TBL] [Abstract][Full Text] [Related]
35. Identification of Broad-Spectrum Antiviral Compounds by Targeting Viral Entry.
Mazzon M; Ortega-Prieto AM; Imrie D; Luft C; Hess L; Czieso S; Grove J; Skelton JK; Farleigh L; Bugert JJ; Wright E; Temperton N; Angell R; Oxenford S; Jacobs M; Ketteler R; Dorner M; Marsh M
Viruses; 2019 Feb; 11(2):. PubMed ID: 30791609
[TBL] [Abstract][Full Text] [Related]
36. Small molecule grp94 inhibitors block dengue and Zika virus replication.
Rothan HA; Zhong Y; Sanborn MA; Teoh TC; Ruan J; Yusof R; Hang J; Henderson MJ; Fang S
Antiviral Res; 2019 Nov; 171():104590. PubMed ID: 31421166
[TBL] [Abstract][Full Text] [Related]
37. Identification of an Arylnaphthalene Lignan Derivative as an Inhibitor against Dengue Virus Serotypes 1 to 4 (DENV-1 to -4) Using a Newly Developed DENV-3 Infectious Clone and Replicon.
Hu M; Li WF; Wu T; Yang Y; Chen G; Chen T; Liu Y; Mei Y; Wu D; Wei Y; Luo T; Zhang HJ; Li YP
Microbiol Spectr; 2023 Aug; 11(4):e0042323. PubMed ID: 37378517
[TBL] [Abstract][Full Text] [Related]
38. Identification of Novel 5,6-Dimethoxyindan-1-one Derivatives as Antiviral Agents.
Patil SA; Patil V; Patil R; Beaman K; Patil SA
Med Chem; 2017; 13(8):787-795. PubMed ID: 28359234
[TBL] [Abstract][Full Text] [Related]
39. Novel Broad-Spectrum Antiviral Inhibitors Targeting Host Factors Essential for Replication of Pathogenic RNA Viruses.
Tampere M; Pettke A; Salata C; Wallner O; Koolmeister T; Cazares-Körner A; Visnes T; Hesselman MC; Kunold E; Wiita E; Kalderén C; Lightowler M; Jemth AS; Lehtiö J; Rosenquist Å; Warpman-Berglund U; Helleday T; Mirazimi A; Jafari R; Puumalainen MR
Viruses; 2020 Dec; 12(12):. PubMed ID: 33322045
[TBL] [Abstract][Full Text] [Related]
40. Small-Molecule Inhibitor of Flaviviral NS3-NS5 Interaction with Broad-Spectrum Activity and Efficacy
Celegato M; Sturlese M; Vasconcelos Costa V; Trevisan M; Lallo Dias AS; Souza Passos IB; Queiroz-Junior CM; Messa L; Favaro A; Moro S; Teixeira MM; Loregian A; Mercorelli B
mBio; 2023 Feb; 14(1):e0309722. PubMed ID: 36622141
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
